Tularemia vaccine: Safety, reactogenicity, “Take” skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain – A phase 2 randomized clinical TrialMark J. Mulligan, Johannes B. Goll, Wilbur H. Chen et al.|Vaccine|2017Cited by 37
Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody ResponsesKathleen M. Neuzil, James E. Crowe, Evan J. Anderson et al.|Clinical Infectious Diseases|2023Cited by 17